[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

A 2023 Update on CAR-T Therapy in Myeloma with Dr. Craig Hofmeister

A 2023 Update on CAR-T Therapy in Myeloma with Dr. Craig Hofmeister  image

A 2023 Update on CAR-T Therapy in Myeloma with Dr. Craig Hofmeister

Webinar
event Feb 02, 2023 / 01:00PM - 02:00PM EST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Dr. Craig Hofmeister, multiple myeloma specialist from Emory, presents an update on the role of CAR-T therapy in multiple myeloma. What products are currently FDA approved and what new products have been developed? Will the product become more widely available? Will it ever become front-line therapy? The answers to these questions and more will be discussed in this important meeting.

Schedule & Agenda

The panelist Audrey Burton-Bethke
01:00 PM
Introductions
Audrey Burton-Bethke

Audrey introduces the agenda of the event and featured speaker Stephanie Wiese.

The panelist Craig Hofmeister
01:05 PM
Presentation
Craig Hofmeister

Dr. Craig Hofmeister presents an update on the role of CAR-T therapy in multiple myeloma.

Event panelist Audience
01:35 PM
Questions and Answers
Audience

Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Craig Hofmeister
Craig Hofmeister

Craig C. Hofmeister, MD, MPH, is Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Board certified in internal medicine and hematology, Dr. Hofmeister’s practice focuses on plasma cell cancers, including plasmacytomas, multiple myeloma, AL amyloidosis, smoldering myeloma, and monoclonal gammopathies of renal significance. He started practicing with Emory Healthcare in 2018.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Treatment & Testing group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.